| Literature DB >> 19309510 |
Séverine Monnerat1, Caroline Clucas, Elaine Brown, Jeremy C Mottram, Tansy C Hammarton.
Abstract
BACKGROUND: The protozoan parasite, Trypanosoma brucei, is spread by the tsetse fly and causes Human African Trypanosomiasis. Its cell cycle is complex and not fully understood at the molecular level. The T. brucei genome contains over 6000 protein coding genes with >50% having no predicted function. A small scale RNA interference (RNAi) screen was carried out in Trypanosoma brucei to evaluate the prospects for identifying novel cycle regulators.Entities:
Year: 2009 PMID: 19309510 PMCID: PMC2674452 DOI: 10.1186/1756-0500-2-46
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1Tertiary screening in the procyclic form. Independent RNAi cell lines generated in PF T. brucei for dynein heavy chain (Tb927.3.930), panel A; TOR1 (Tb10.6k15.2060), panel B; TOR-like 2 kinase (Tb927.1.1930), panel C and a hypothetical ORF (Tb927.5.3260), panel D, were analysed for cell cycle progression defects following RNAi induction. Upper left of each panel: cumulative growth curves for each clone cultured in SDM79 with appropriate selective drugs [13,14] and the absence (-tet) or presence (+tet) of 1 μgml-1 tetracycline. Lower left of each panel: real time PCR analysis of mRNA levels for each gene (using oligonucleotides detailed in Additional file 5 and standardised against a GPI8 control) at 96 hrs (dynein heavy chain and hypothetical ORF), 161 hrs (TOR-like 2 kinase) or 212 hrs (TOR1) post-induction. Middle of each panel: analysis of nuclei and kinetoplast numbers as determined over time by DAPI staining. Upper right of panels A and D and right of panels B and C: flow cytometry profiles of uninduced (-tet) and induced (+tet) cells at the time points indicated. The DNA content of each peak is given. Lower right panels A and D: examples of abnormal cells generated. Left, DIC image; right, DAPI image. Black bar: 5 μm. The number of nuclei (N) and kinetoplasts (K) in each cell is given.
Figure 2Tertiary screening in the bloodstream stage. Analysis of RNAi cell lines generated in BS T. brucei for dynein heavy chain (Tb927.3.930, Panel A), hypothetical ORF (Tb927.5.3260, Panel B) and protein phosphatase 1 (Tb11.01.0450, Panel C). Panels A and B, upper left and Panel C, left: cumulative growth curves for each clone cultured in HMI9 with appropriate selective drugs [13,14] in the absence (-tet) or presence (+tet) of tetracycline; Panels A and B, lower left and Panel C, middle: analysis of nuclei and kinetoplast numbers as determined over time by DAPI staining; Panels A and B, upper right and Panel C, right: flow cytometry profiles at the time points indicated; Panels A and B, lower right: examples of abnormal cells generated (left, DIC image; right, DAPI image. Black bar: 5 μm. The number of nuclei (N) and kinetoplasts (K) in each cell is given). Panel D: real time PCR analysis of mRNA levels for each gene (standardised against a GPI8 endogenous control, using oligonucleotides detailed in Additional file 5) at 6.5 hrs (dynein heavy chain) and 16 hrs (hypothetical ORF and PP1) post-induction.